UC Santa Cruz team separates psilocybin's therapeutic effects from hallucinations in mice
Researchers identified distinct neural pathways for psilocybin's brain-connectivity benefits and its hallucinogenic effects, opening a path to targeted treatments.
What to know
- UC Santa Cruz researchers identified two separate neural pathways in psilocybin: one for neuroplasticity and dendritic spine growth, another for hallucinations.
- By genetically manipulating cellular receptors, the team isolated therapeutic brain benefits from psychedelic effects in mice—moving closer to targeted treatments without the 'trip.'
- Effects differ based on brain state: stressed mice showed greater spine formation and connection preservation, while healthy mice showed accelerated spine production and clearing.
- Results are early-stage mouse studies; human translation needed before any new treatments can be developed.
“These newly formed connections can integrate into existing neural circuitry and persist over time, leaving a lasting structural trace of psilocybin's effects on the brain.”
Jacob Baker, Neuroscientist · ScienceAlert ↗ · Nov 1
Yi Zuo Molecular biologist, UC Santa CruzJacob Baker NeuroscientistUniversity of California, Santa Cruz Research institution
How it unfolded 1 development · click the chart to see its coverage articlesposts
-
1
Findings reveal psilocybin's therapeutic effects depend on brain's underlying condition
The research shows psilocybin's effects differ based on whether the brain is stressed or healthy. In stressed mice (mimicking depression), new spine formation increased more dramatically and existing connection loss was prevented, while in healthy mice both spine production and clearing accelerated.
“These findings challenge the prevailing view that psilocybin simply increases neural connectivity and suggest that its effects depend on the brain's underlying condition.”
— Yi Zuo -
background
UC Santa Cruz team isolates psilocybin's therapeutic pathway from hallucinations in mouse study — Researchers published findings in Nature Neuroscience showing that psilocybin can boost brain connectivity and dendritic spine development without producing hallucinogenic effects. The team manipulated cellular receptors to separate the neuroplasticity benefits from trip-like responses, assessed via head-twitch proxies in the animals.